University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore's second NCI comprehensive centre, with the Maryland Proton Treatment Center and the GammaPod breast radiotherapy system invented on campus.
NCI-designated in 2008 and comprehensive since 2016, the Greenebaum Comprehensive Cancer Center serves Baltimore and the state of Maryland alongside Johns Hopkins. Radiation oncology is a signature strength: the Maryland Proton Treatment Center opened in 2016, and the GammaPod, a stereotactic radiotherapy device for breast cancer, was invented at the University of Maryland. The centre runs a large blood and marrow transplant programme and early engineered T-cell trials in myeloma, and studies cancer disparities in Baltimore's Black population.
- Proton therapy
- Stereotactic breast radiotherapy (GammaPod)
- Transplant and cellular therapy
Pages like this
not linked directly; found by shared links- InstitutionApollo Hospitals (Apollo Cancer Centres)
Shares Proton therapy, SBRT / SABR (stereotactic radiotherapy), HR-positive / HER2-negative breast cancer.
- InstitutionSylvester Comprehensive Cancer Center, University of Miami
Shares Proton therapy, Trials do not represent the people who get cancer, Multiple myeloma.
- IdeaFix the neutrophil count rule that excludes many people of African ancestry
Shares Trials do not represent the people who get cancer, Multiple myeloma.
- InstitutionHokkaido University Hospital
Shares Proton therapy, SBRT / SABR (stereotactic radiotherapy).
- PersonTheodore S. Hong
Shares Proton therapy, SBRT / SABR (stereotactic radiotherapy).
- InstitutionVCU Massey Comprehensive Cancer Center
Shares Trials do not represent the people who get cancer, Multiple myeloma.
- InstitutionRoyal Adelaide Hospital
Shares Proton therapy, HR-positive / HER2-negative breast cancer.
- PersonJohn F. DiPersio
Shares Allogeneic stem cell transplantation, Multiple myeloma.